Abstract |
Ceftazidime ( CAZ ), a new cephalosporin antibiotic, was fundamentally and clinically studied. The following results were obtained. Serum and internal genital tissue levels of CAZ were measured following intravenous drip infusion of 1 g for 30 minutes. Serum levels of more than 10 micrograms/ml and tissue levels of more than about 7 micrograms/ml were maintained after 2 hours to 2 hours and 30 minutes, respectively. Favourable transfer of CAZ into the pelvic dead space exudate was observed. The exudate level attained its peak of 31.54 micrograms/ml on average at 2 hours and was 16.8 micrograms/ml on average even at 8 hours after intravenous drip infusion. A total of 6 cases comprising 1 of adnexitis, 2 of pyometra, 1 of endometritis and 2 of parametritis was treated with CAZ at a dose of 0.5 approximately 2.0 g twice daily by intravenous injection or intravenous drip infusion. The clinical response was excellent in 1 case, good in 4 cases and poor in 1 case. Abnormal laboratory findings and side effects due to the drug were not noted.
|
Authors | M Shintani, K Takashima, H Kosakai, T Takayama, A Nakanishi, I Shimamoto, M Ichijo |
Journal | The Japanese journal of antibiotics
(Jpn J Antibiot)
Vol. 37
Issue 1
Pg. 28-32
(Jan 1984)
ISSN: 0368-2781 [Print] Japan |
PMID | 6374196
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Cephalosporins
- Ceftazidime
|
Topics |
- Adult
- Bacterial Infections
(drug therapy)
- Ceftazidime
- Cephalosporins
(administration & dosage, metabolism, therapeutic use)
- Drug Evaluation
- Female
- Genital Diseases, Female
(drug therapy)
- Genitalia, Female
(metabolism)
- Humans
- Infusions, Parenteral
- Middle Aged
- Pelvis
|